Stocks in the Drugs Industry Trading Higher Today

AstraZeneca, Sanofi, and Eli Lilly are among the top performers in the Drugs industry, with shares of each company trading higher today. Despite some negative performers within the industry, including Catalent, Alnylam Pharmaceuticals, and Perrigo, these three stocks are helping to drive the industry's upward momentum. TheStreet Ratings has analyzed each of these companies and provided its rating and recommendations.

Key Takeaways:

• AstraZeneca (AZN) is up 1.7% to $32.22 on average volume, with 1.3 million shares exchanged hands as compared to its average daily volume of 2.5 million shares.
• Sanofi (SNY) is up 0.8% to $49.63 on light volume, with 643,202 shares exchanged hands as compared to its average daily volume of 1.8 million shares.
• Eli Lilly and Company (LLY) is up 0.5% to $82.25 on light volume, with 1.7 million shares exchanged hands as compared to its average daily volume of 5.8 million shares.
• TheStreet Ratings has rated AstraZeneca as a hold, Sanofi as a buy, and Eli Lilly and as a buy, citing strengths in each company's financial position, profit margins, and stock price performance.
• The three companies have market caps of $77.6 billion (AZN), $126.1 billion (SNY), and $88.5 billion (LLY), and are part of the health care sector.
• AstraZeneca has a P/E ratio of 30.1, while Sanofi and Eli Lilly and have P/E ratios of 25.9 and 41.4, respectively.

Statistics:

• The Dow Jones Industrial Average (DJI) is up 95 points (0.6%) to 16,447 as of Thursday, Sept. 3, 2015, 12:55 PM ET.
• The NYSE advances/declines ratio sits at 2,140 issues advancing vs. 838 declining with 150 unchanged.
• The Drugs industry is currently down 0.8% versus the S&P 500, which is up 0.5%.

Sources:

• TheStreet Wire, "Stocks in the Drugs Industry Trading Higher Today" September 3, 2015.
• NASDAQ, "AstraZeneca" September 3, 2015.
• Bloomberg, "Sanofi" September 3, 2015.
• Eli Lilly and Company Investor Relations, "Investor Relations" September 3, 2015.